Joseph Vazzano
2019 - AVENUE THERAPEUTICS
In 2019, Joseph Vazzano earned a total compensation of $258.8K as Chief Financial Officer at AVENUE THERAPEUTICS, a 27% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $50,000 |
|---|---|
| Salary | $198,113 |
| Other | $10,666 |
| Total | $258,779 |
Vazzano received $198.1K in salary, accounting for 77% of the total pay in 2019.
Vazzano also received $50K in non-equity incentive plan and $10.7K in other compensation.
Rankings
In 2019, Joseph Vazzano's compensation ranked 13,173rd out of 13,971 executives tracked by ExecPay. In other words, Vazzano earned more than 5.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13,173 out of 13,971 | 6th |
Division Manufacturing | 5,357 out of 5,695 | 6th |
Major group Chemicals And Allied Products | 2,088 out of 2,194 | 5th |
Industry group Drugs | 1,791 out of 1,880 | 5th |
Industry Pharmaceutical Preparations | 1,322 out of 1,392 | 5th |
Source: SEC filing on April 29, 2020.
Vazzano's colleagues
We found one more compensation record of an executive who worked with Joseph Vazzano at AVENUE THERAPEUTICS in 2019.
2019
Lucy Lu
AVENUE THERAPEUTICS
Chief Executive Officer
News
Abeona Therapeutics CEO Vishwas Seshadri's 2023 pay jumps 90% to $2.8M
March 19, 2024
Abeona Therapeutics CEO Vishwas Seshadri's 2022 pay slips 4% to $1.5M
April 13, 2023
AVENUE THERAPEUTICS CEO Lucy Lu's 2021 pay jumps 144% to $1.1M
November 18, 2022
AVENUE THERAPEUTICS CEO Lucy Lu's 2020 pay falls 31% to $443K
November 23, 2021
AVENUE THERAPEUTICS CEO Lucy Lu's 2019 pay falls 60% to $640K
April 29, 2020
AVENUE THERAPEUTICS CEO Lucy Lu's 2018 pay falls 22% to $1.6M
April 30, 2019